|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5614184A
(en)
*
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
|
US5696250A
(en)
|
1995-02-15 |
1997-12-09 |
Amgen Inc. |
DNA encoding megakaryocyte growth and development factor analogs
|
|
US5989538A
(en)
*
|
1995-02-15 |
1999-11-23 |
Amgen Inc. |
Mpl ligand analogs
|
|
AU6964196A
(en)
*
|
1995-10-09 |
1997-04-30 |
Pharmacia & Upjohn Company |
An acceptor polypeptide for an n-acetylgalactosaminyltransferase
|
|
KR100400637B1
(ko)
*
|
1996-02-06 |
2004-03-10 |
씨제이 주식회사 |
생물학적으로유용한펩타이드
|
|
DK0888385T3
(da)
|
1996-03-14 |
2003-12-15 |
Genentech Inc |
GDNF receptor og anvendelser deraf
|
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
|
PT902085E
(pt)
*
|
1997-09-01 |
2004-02-27 |
Aventis Pharma Gmbh |
Eritropoietina humana recombinante com perfil de glicosilacao vantajoso
|
|
EP1489100B1
(en)
|
1997-12-08 |
2016-06-15 |
Merck Patent GmbH |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
|
|
CA2330527A1
(en)
|
1998-06-15 |
1999-12-23 |
Genzyme Transgenics Corporation |
Erythropoietin analog-human serum albumin fusion
|
|
ES2347884T3
(es)
*
|
1998-10-23 |
2010-11-22 |
Amgen Inc. |
Metodo y composiciones para la prevenciã“n y tratamiento de la anemia.
|
|
US7304150B1
(en)
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
DE19857609A1
(de)
|
1998-12-14 |
2000-06-15 |
Hannelore Ehrenreich |
Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
|
|
CA2359840C
(en)
*
|
1999-02-12 |
2012-10-23 |
Amgen Inc. |
Glycosylated leptin compositions and related methods
|
|
US7410941B1
(en)
|
1999-04-13 |
2008-08-12 |
The Kenneth S. Warren Institute, Inc. |
Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
|
|
US7345019B1
(en)
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
|
US8236561B2
(en)
|
1999-04-15 |
2012-08-07 |
Crucell Holland B.V. |
Efficient production of IgA in recombinant mammalian cells
|
|
US7604960B2
(en)
|
1999-04-15 |
2009-10-20 |
Crucell Holland B.V. |
Transient protein expression methods
|
|
US6855544B1
(en)
|
1999-04-15 |
2005-02-15 |
Crucell Holland B.V. |
Recombinant protein production in a human cell
|
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
US6555343B1
(en)
|
1999-05-07 |
2003-04-29 |
Genentech Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
|
US6831060B2
(en)
|
1999-05-07 |
2004-12-14 |
Genentech, Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
|
AU766507B2
(en)
*
|
1999-05-07 |
2003-10-16 |
Genentech Inc. |
Novel chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
|
JO2291B1
(en)
*
|
1999-07-02 |
2005-09-12 |
اف . هوفمان لاروش ايه جي |
Erythropoietin derivatives
|
|
CZ299516B6
(cs)
*
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
US7067110B1
(en)
|
1999-07-21 |
2006-06-27 |
Emd Lexigen Research Center Corp. |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
ATE316982T1
(de)
|
1999-08-09 |
2006-02-15 |
Lexigen Pharm Corp |
Mehrere zytokin-antikörper komplexen
|
|
CA2391080A1
(en)
*
|
1999-11-12 |
2001-05-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Erythropoietin forms with improved properties
|
|
US7192759B1
(en)
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7527961B2
(en)
|
1999-11-26 |
2009-05-05 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
ES2269366T3
(es)
|
2000-02-11 |
2007-04-01 |
Merck Patent Gmbh |
Mejoramiento de la vida media en circulacion de proteinas de fusion basadas en anticuerpos.
|
|
US6586398B1
(en)
*
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
US20030199043A1
(en)
|
2000-04-12 |
2003-10-23 |
Ballance David J. |
Albumin fusion proteins
|
|
EP1274728B1
(en)
*
|
2000-04-21 |
2008-05-14 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
AU784091B2
(en)
|
2000-05-15 |
2006-02-02 |
F. Hoffmann-La Roche Ag |
New pharmaceutical composition
|
|
US7259146B2
(en)
|
2000-05-26 |
2007-08-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Neuroprotective peptides
|
|
BR0112111A
(pt)
|
2000-06-29 |
2003-05-06 |
Merck Patent Gmbh |
Realce de respostas imunes mediadas por proteìna de fusão de anticorpo-citocina por tratamento combinado com agentes de realce de captação de imunocitocina
|
|
EP1336410A4
(en)
|
2000-08-04 |
2005-10-12 |
Chugai Pharmaceutical Co Ltd |
PROTEIN INJECTION PREPARATIONS
|
|
WO2002013860A1
(fr)
|
2000-08-11 |
2002-02-21 |
Chugai Seiyaku Kabushiki Kaisha |
Preparations stabilisees contenant un anticorps
|
|
KR101229995B1
(ko)
*
|
2000-12-11 |
2013-02-06 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
EP1342730B1
(en)
*
|
2000-12-11 |
2006-03-15 |
Cheil Jedang Corporation |
Fusion protein having the enhanced in vivo activity of erythropoietin
|
|
JP4656814B2
(ja)
|
2000-12-20 |
2011-03-23 |
エフ．ホフマン−ラ ロシュ アーゲー |
エリスロポエチンコンジュゲート
|
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
|
US20030072737A1
(en)
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
|
US7767643B2
(en)
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
US6531121B2
(en)
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
ES2284858T3
(es)
|
2001-02-02 |
2007-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Tratamiento de disfuncion neurologica que comprende sulfamatos de fructopiranosa y eritropoyetina.
|
|
ES2393733T3
(es)
|
2001-03-07 |
2012-12-27 |
Merck Patent Gmbh |
Tecnología de expresión para proteínas que contienen una fracción de anticuerpo de isotipo híbrido
|
|
ES2869895T3
(es)
|
2001-03-09 |
2021-10-26 |
Chugai Pharmaceutical Co Ltd |
Método de purificación de proteínas
|
|
DE10112825A1
(de)
|
2001-03-16 |
2002-10-02 |
Fresenius Kabi De Gmbh |
HESylierung von Wirkstoffen in wässriger Lösung
|
|
US6992174B2
(en)
|
2001-03-30 |
2006-01-31 |
Emd Lexigen Research Center Corp. |
Reducing the immunogenicity of fusion proteins
|
|
FR2823220B1
(fr)
*
|
2001-04-04 |
2003-12-12 |
Genodyssee |
Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
|
|
JP4236934B2
(ja)
|
2001-04-17 |
2009-03-11 |
中外製薬株式会社 |
界面活性剤の定量方法
|
|
CN100503639C
(zh)
|
2001-05-03 |
2009-06-24 |
默克专利有限公司 |
重组肿瘤特异性抗体及其应用
|
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
|
BR0214557A
(pt)
|
2001-11-28 |
2006-06-06 |
Ortho Mcneil Pharm Inc |
regime de dosagem de eritropoietina para o tratamento de anemia
|
|
KR100467750B1
(ko)
*
|
2001-11-29 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
KR100467751B1
(ko)
*
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
EP1454138B1
(en)
|
2001-12-04 |
2012-01-18 |
Merck Patent GmbH |
Immunocytokines with modulated selectivity
|
|
DE60224843T2
(de)
|
2001-12-07 |
2009-01-08 |
Crucell Holland B.V. |
Herstellung von viren, virusisolaten, und impfstoffen
|
|
JP5424521B2
(ja)
|
2001-12-21 |
2014-02-26 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
アルブミン融合タンパク質
|
|
DE10209822A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
|
|
DE10209821A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
|
WO2003078959A2
(en)
|
2002-03-11 |
2003-09-25 |
Ortho Mcneil Pharmaceutical, Inc |
Methods for shp1 mediated neuroprotection
|
|
US20030191056A1
(en)
|
2002-04-04 |
2003-10-09 |
Kenneth Walker |
Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
|
|
US20040122216A1
(en)
*
|
2002-07-01 |
2004-06-24 |
Jacob Nielsen |
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
|
|
WO2004009627A1
(en)
*
|
2002-07-19 |
2004-01-29 |
Cangene Corporation |
Pegylated erythropoietic compounds
|
|
DE10234192B4
(de)
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
WO2004019966A1
(ja)
|
2002-08-27 |
2004-03-11 |
Chugai Seiyaku Kabushiki Kaisha |
タンパク質溶液製剤の安定化方法
|
|
US7459435B2
(en)
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
|
ES2343518T3
(es)
*
|
2002-09-09 |
2010-08-03 |
Hanall Biopharma Co., Ltd. |
Polipeptidos interferon alfa modificados resistentes a proteasas.
|
|
EP1681303B1
(en)
|
2002-09-11 |
2013-09-04 |
Fresenius Kabi Deutschland GmbH |
HASylated polypeptides, especially HASylated erythropoietin
|
|
DE20321793U1
(de)
|
2002-09-11 |
2010-06-02 |
Fresenius Kabi Deutschland Gmbh |
Hydroxyalkylstärke-Derivate
|
|
EP3225625A1
(en)
|
2002-09-11 |
2017-10-04 |
Chugai Seiyaku Kabushiki Kaisha |
Protein purification method
|
|
KR101174510B1
(ko)
|
2002-09-11 |
2012-08-16 |
프레제니우스 카비 도이치란트 게엠베하 |
하이드록시알킬전분화 폴리펩티드, 특히 하이드록시알킬전분화 에리트로포이에틴
|
|
US7538092B2
(en)
|
2002-10-08 |
2009-05-26 |
Fresenius Kabi Deutschland Gmbh |
Pharmaceutically active oligosaccharide conjugates
|
|
US20060142220A1
(en)
*
|
2002-10-17 |
2006-06-29 |
Berkel Patrick V |
Protein modification
|
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
|
ATE471946T1
(de)
|
2002-12-17 |
2010-07-15 |
Merck Patent Gmbh |
Humanisierter antikörper (h14.18) des maus antikörpers 14.18, der gd2 bindet und seine fusion mit il-2
|
|
CA2513213C
(en)
|
2003-01-22 |
2013-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
NZ542586A
(en)
|
2003-04-09 |
2009-11-27 |
Biogenerix Ag |
Method of forming a covalent conjugate between a G-CSF peptide and PEG
|
|
KR101183770B1
(ko)
|
2003-05-09 |
2012-09-17 |
크루셀 홀란드 비.브이. |
Ｅ1-불멸화된 세포의 배양물 및 이로부터 생성 수율을 증가시키기 위한 동일물의 배양 방법
|
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
|
WO2005014655A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
|
BRPI0414887A
(pt)
|
2003-09-29 |
2006-12-12 |
Warren Pharmaceuticals Inc E T |
métodos de tratamento, prevenção, retardo do inìcio ou redução dos efeitos de citocinas pró-inflamatórias em um mamìfero e de tratamento, prevenção, retardo do inìcio de uma condição associada com um efeito de citocinas pró-inflamatórias em um mamìfero, e, composição farmacêutica
|
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
DE502004011252D1
(de)
|
2003-12-30 |
2010-07-15 |
Augustinus Bader |
Verwendung des erythropoietins zur regeneration von lebergewebe
|
|
AU2004309063B2
(en)
|
2003-12-31 |
2010-10-28 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
|
DE102004004509B4
(de)
|
2004-01-23 |
2010-07-01 |
Epoplus Gmbh Co.Kg |
Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
|
|
DE202005021885U1
(de)
|
2004-03-11 |
2011-03-03 |
Fresenius Kabi Deutschland Gmbh |
Hydroxyalkylstärke-Protein-Konjugate, durch reduktive Aminierung hergestellt
|
|
US20080300173A1
(en)
|
2004-07-13 |
2008-12-04 |
Defrees Shawn |
Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
ES2566670T3
(es)
|
2004-10-29 |
2016-04-14 |
Ratiopharm Gmbh |
Remodelación y glucopegilación del factor de crecimiento de fibroblastos (FGF)
|
|
AU2006203792B2
(en)
|
2005-01-10 |
2011-11-03 |
Ratiopharm Gmbh |
Glycopegylated Granulocyte Colony Stimulating Factor
|
|
EP1871795A4
(en)
|
2005-04-08 |
2010-03-31 |
Biogenerix Ag |
COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
|
|
EP1736481A1
(en)
|
2005-05-13 |
2006-12-27 |
Charite Universitätsmedizin-Berlin |
Erythropoietin variants
|
|
US9988427B2
(en)
|
2005-05-13 |
2018-06-05 |
Charite Universitaetsmedizen-Berlin |
Erythropoietin variants
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
CN100432107C
(zh)
*
|
2005-10-25 |
2008-11-12 |
北京大学 |
具有促红细胞生长因子活性的蛋白质及其用途
|
|
WO2007056191A2
(en)
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
|
WO2007067564A2
(en)
|
2005-12-08 |
2007-06-14 |
Amgen Inc. |
Improved host cells and culture methods
|
|
EP2495308A1
(en)
|
2005-12-08 |
2012-09-05 |
Amgen Inc. |
Improved production of glycoproteins using manganese
|
|
DE102006004008A1
(de)
|
2006-01-27 |
2007-08-02 |
Hannelore Prof. Dr. Dr. Ehrenreich |
Verfahren zur Behandlung und/oder Prophylaxe von Multipler Sklerose, sowie Verwendung von Erythropoietin zur Herstellung eines Arzneimittels zur intermittierenden Behandlung und/oder intermittierenden Prophylaxe von Multipler Sklerose
|
|
JP5553506B2
(ja)
|
2006-03-22 |
2014-07-16 |
中外製薬株式会社 |
エリスロポエチン溶液製剤
|
|
CN101062407A
(zh)
|
2006-04-29 |
2007-10-31 |
中国科学院上海生命科学研究院 |
促红细胞生成素在预防或治疗视网膜损伤中的用途
|
|
US7851438B2
(en)
|
2006-05-19 |
2010-12-14 |
GlycoFi, Incorporated |
Erythropoietin compositions
|
|
JP2009544327A
(ja)
|
2006-07-21 |
2009-12-17 |
ノヴォ ノルディスク アー／エス |
Ｏ−結合型グリコシル化配列によるペプチドのグリコシル化
|
|
WO2008011158A2
(en)
|
2006-07-21 |
2008-01-24 |
Amgen Inc. |
Method of detecting and/ or measuring hepcidin in a sample
|
|
EP2057997A4
(en)
|
2006-08-22 |
2012-11-07 |
Chugai Pharmaceutical Co Ltd |
MEANS FOR THE PREVENTION AND / OR TREATMENT OF PERIPHERAL NEUROPATHY
|
|
WO2008057683A2
(en)
|
2006-10-03 |
2008-05-15 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
|
CN101337988B
(zh)
*
|
2006-10-31 |
2013-01-09 |
沈阳三生制药有限责任公司 |
一种新的促红细胞生成素类似物
|
|
US8895303B2
(en)
|
2006-11-13 |
2014-11-25 |
Charite-Universitatsmedizin Berlin |
Method of cell culture and method of treatment comprising a vEPO protein variant
|
|
JP2010510794A
(ja)
|
2006-11-28 |
2010-04-08 |
ハナル ファーマシューティカル カンパニー リミテッド |
修飾型エリスロポエチンポリペプチド及びこの治療用用途
|
|
AR065613A1
(es)
|
2007-03-09 |
2009-06-17 |
Chugai Pharmaceutical Co Ltd |
Agentes de proteccion para organos transplantados
|
|
RS52845B
(en)
|
2007-04-03 |
2013-12-31 |
Biogenerix Ag |
TREATMENT PROCEDURES USING GLYCOPEGILATED G-CSF
|
|
US9493499B2
(en)
|
2007-06-12 |
2016-11-15 |
Novo Nordisk A/S |
Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
|
|
JP2010534194A
(ja)
*
|
2007-06-15 |
2010-11-04 |
チューリッヒ大学 |
神経系障害の新規な処置法
|
|
CN103073631A
(zh)
*
|
2007-07-02 |
2013-05-01 |
沈阳三生制药有限责任公司 |
一种促红细胞生成素类似物
|
|
CN103113464B
(zh)
*
|
2007-07-02 |
2014-08-20 |
沈阳三生制药有限责任公司 |
天然人促红细胞生成素类似物
|
|
WO2009010107A1
(en)
|
2007-07-19 |
2009-01-22 |
Hannelore Ehrenreich |
Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis
|
|
CA2701032C
(en)
|
2007-09-27 |
2021-01-26 |
Amgen Inc. |
Pharmaceutical formulations
|
|
ES2962777T3
(es)
|
2007-11-15 |
2024-03-21 |
Amgen Inc |
Formulación acuosa de anticuerpos estabilizada por antioxidantes para la administración parenteral
|
|
EP2070950A1
(en)
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Hydroxyalkyl starch derivatives and process for their preparation
|
|
CA2711826C
(en)
|
2008-01-25 |
2018-02-27 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
|
CN103694337B
(zh)
|
2008-02-08 |
2016-03-02 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
|
EP2095829A1
(en)
|
2008-02-27 |
2009-09-02 |
LEK Pharmaceuticals D.D. |
Selenium containing modifying agents and conjugates
|
|
RU2573587C2
(ru)
|
2008-02-27 |
2016-01-20 |
Ново Нордиск А/С |
Конъюгированные молекулы фактора viii
|
|
US20110137011A1
(en)
|
2008-04-21 |
2011-06-09 |
Novo Nordisk A/S |
Hyperglycosylated human coagulation factor ix
|
|
AU2009246946B2
(en)
|
2008-05-01 |
2013-09-26 |
Amgen Inc. |
Anti-hepcidin antibodies and methods of use
|
|
US20120172299A1
(en)
|
2008-09-23 |
2012-07-05 |
F. Hoffmann-La Roche Ag |
Purification of erythropoietin
|
|
JP5694171B2
(ja)
|
2008-09-26 |
2015-04-01 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
修飾されている動物のエリスロポエチンポリペプチドおよびそれらの使用
|
|
CN104922669A
(zh)
|
2008-11-13 |
2015-09-23 |
通用医疗公司 |
用于通过调整bmp-6来调节铁稳态的方法和组合物
|
|
CN102325785B
(zh)
*
|
2009-02-19 |
2015-01-21 |
埃克斯利亚制药有限公司 |
用于纯化脂肽的方法
|
|
US20100272816A1
(en)
|
2009-04-27 |
2010-10-28 |
Wolfgang Rudinger |
Microcapsules comprising liver cells and erythropoietin, methods for preparing said microcapsules and methods for treating a patient comprising applying said microcapsules to the patient
|
|
WO2011011674A2
(en)
|
2009-07-24 |
2011-01-27 |
Dr. Reddy's Laboratories Ltd. |
Production of erythropoiesis stimulating protein using metal ions
|
|
WO2011024025A1
(en)
*
|
2009-08-28 |
2011-03-03 |
Avesthagen Limited |
An erythropoietin analogue and a method thereof
|
|
AU2010310457B2
(en)
|
2009-10-23 |
2015-07-02 |
Amgen Inc. |
Vial adapter and system
|
|
SG194370A1
(en)
|
2010-06-07 |
2013-11-29 |
Amgen Inc |
Drug delivery device
|
|
US8193296B2
(en)
|
2010-06-30 |
2012-06-05 |
Nike, Inc. |
Golf balls including crosslinked thermoplastic polyurethane
|
|
US20120115637A1
(en)
|
2010-06-30 |
2012-05-10 |
Nike, Inc. |
Golf Balls Including A Crosslinked Thermoplastic Polyurethane Cover Layer Having Improved Scuff Resistance
|
|
RU2451071C1
(ru)
*
|
2010-12-10 |
2012-05-20 |
Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) |
Штамм гибридных культивируемых клеток животных mus musculus - продуцент моноклональных антител к рекомбинантному эритропоэтину человека (варианты)
|
|
AU2012236573B2
(en)
|
2011-03-31 |
2016-06-02 |
Amgen Inc. |
Vial adapter and system
|
|
HUE042822T2
(hu)
|
2011-04-20 |
2019-07-29 |
Amgen Inc |
Automata befecskendezõ szerkezet
|
|
US9089739B2
(en)
|
2011-08-23 |
2015-07-28 |
Nike, Inc. |
Multi-core golf ball having increased initial velocity
|
|
US8979676B2
(en)
|
2011-08-23 |
2015-03-17 |
Nike, Inc. |
Multi-core golf ball having increased initial velocity at high swing speeds relative to low swing speeds
|
|
CA2851521C
(en)
|
2011-10-14 |
2020-09-22 |
Amgen Inc. |
Injector and method of assembly
|
|
KR101443257B1
(ko)
*
|
2011-10-18 |
2014-09-19 |
주식회사 종근당 |
낮은 등전점을 갖는 에리스로포이에틴 유사체의 정제방법
|
|
CN102788720B
(zh)
*
|
2012-06-05 |
2016-01-06 |
西北大学 |
一种滤膜辅助分离生物样本中糖蛋白全n-连接糖链及其鉴别方法
|
|
SI3081249T1
(sl)
|
2012-11-21 |
2021-03-31 |
Amgen Inc. |
Naprava za dajanje zdravila
|
|
CN103864913A
(zh)
|
2012-12-18 |
2014-06-18 |
联亚生技开发股份有限公司 |
重组蛋白
|
|
DK2968503T3
(en)
|
2013-03-15 |
2018-12-03 |
Intrinsic Lifesciences Llc |
ANTI-HEPCIDIN ANTIBODIES AND APPLICATIONS THEREOF
|
|
TWI639453B
(zh)
|
2013-03-15 |
2018-11-01 |
美商安美基公司 |
用於注射器之匣盒
|
|
TWI592183B
(zh)
|
2013-03-15 |
2017-07-21 |
安美基公司 |
本體輪廓可調適之自動注射器裝置
|
|
ES2973257T3
(es)
|
2013-03-15 |
2024-06-19 |
Amgen Inc |
Casete de fármaco, autoinyector y sistema de autoinyector
|
|
MX2015013533A
(es)
|
2013-03-22 |
2016-02-05 |
Amgen Inc |
Inyector y metodo de montaje.
|
|
SG11201602876WA
(en)
|
2013-10-24 |
2016-05-30 |
Amgen Inc |
Injector and method of assembly
|
|
US10758683B2
(en)
|
2013-10-24 |
2020-09-01 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
|
KR101414897B1
(ko)
|
2013-11-29 |
2014-07-04 |
씨제이헬스케어 주식회사 |
다베포에틴 알파의 정제 방법
|
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
WO2015171777A1
(en)
|
2014-05-07 |
2015-11-12 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
|
CN113990437A
(zh)
|
2014-06-03 |
2022-01-28 |
安姆根有限公司 |
用于远程处理由药物递送装置收集的数据的系统和方法
|
|
US10287336B2
(en)
|
2014-09-18 |
2019-05-14 |
AskGene Pharma, Inc. |
Feline erythropoietin receptor agonists
|
|
EP3197915A4
(en)
|
2014-09-22 |
2018-12-19 |
Intrinsic Lifesciences LLC |
Humanized anti-hepcidin antibodies and uses thereof
|
|
EP3206739B1
(en)
|
2014-10-14 |
2021-12-01 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
ES2785311T3
(es)
|
2014-12-19 |
2020-10-06 |
Amgen Inc |
Dispositivo de administración de fármacos con botón móvil o campo de interfaz de usuario
|
|
MX2017010466A
(es)
|
2015-02-17 |
2018-06-06 |
Amgen Inc |
Dispositivo de administracion de farmacos con sujecion asistida de vacio y/o respuestas.
|
|
ES2905870T3
(es)
|
2015-02-27 |
2022-04-12 |
Amgen Inc |
Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
EP3386573B1
(en)
|
2015-12-09 |
2019-10-02 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
JP6906497B2
(ja)
*
|
2016-03-09 |
2021-07-21 |
Ｊｃｒファーマ株式会社 |
変異型ヒトエリスロポエチンの製造方法
|
|
EP4035711A1
(en)
|
2016-03-15 |
2022-08-03 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
EP3455142B1
(en)
|
2016-05-13 |
2023-08-09 |
Amgen Inc. |
Vial sleeve assembly
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
GB2550418A
(en)
|
2016-05-20 |
2017-11-22 |
Laing Peter |
An improved vaccine against flaviviruses avoiding elicitation or stimulation of infection-enhancing antibodies
|
|
EP3465124A1
(en)
|
2016-06-03 |
2019-04-10 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
|
MX2019008432A
(es)
|
2017-01-17 |
2019-11-18 |
Amgen Inc |
Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje.
|
|
CA3048520A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
US11369736B2
(en)
|
2017-02-17 |
2022-06-28 |
Amgen Inc. |
Cannula insertion and retraction mechanisms
|
|
JP6258536B1
(ja)
*
|
2017-03-03 |
2018-01-10 |
協和発酵キリン株式会社 |
ダルベポエチン組成物の製造方法およびダルべポエチン産生細胞の培養方法
|
|
MX2019010544A
(es)
|
2017-03-06 |
2019-10-21 |
Amgen Inc |
Dispositivo de administracion de farmacos con caracteristica de prevencion de la activacion.
|
|
EP3592402A1
(en)
|
2017-03-07 |
2020-01-15 |
Amgen Inc. |
Needle insertion by overpressure
|
|
SG11201908062QA
(en)
|
2017-03-09 |
2019-09-27 |
Amgen Inc |
Insertion mechanism for drug delivery device
|
|
JP2020511499A
(ja)
|
2017-03-20 |
2020-04-16 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
赤血球生成刺激タンパク質のインビトロでの糖鎖改変のための方法
|
|
MX2019011416A
(es)
|
2017-03-28 |
2019-11-01 |
Amgen Inc |
Sistema y metodo para conjunto de jeringa y vastago de embolo.
|
|
WO2018226747A1
(en)
|
2017-06-06 |
2018-12-13 |
Kindred Biosciences, Inc. |
Erythropoietin and analogs for veterinary use
|
|
CA3066399A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Torque driven drug delivery device
|
|
WO2018226515A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
MA49447A
(fr)
|
2017-06-22 |
2020-04-29 |
Amgen Inc |
Réduction des impacts/chocs d'activation d'un dispositif
|
|
CA3063921A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
|
ES2972207T3
(es)
|
2017-07-14 |
2024-06-11 |
Amgen Inc |
Sistema de inserción-retracción de agujas con sistema de resorte de torsión doble
|
|
IL271173B2
(en)
|
2017-07-21 |
2024-04-01 |
Amgen Inc |
Gas permeable sealing element for drug container and methods of assembly
|
|
JP2020528296A
(ja)
|
2017-07-25 |
2020-09-24 |
アムジエン・インコーポレーテツド |
ギヤモジュールを有する薬物送達デバイス及び関連する組立方法
|
|
JP7242562B2
(ja)
|
2017-07-25 |
2023-03-20 |
アムジエン・インコーポレーテツド |
容器アクセスシステムを有する薬物送達デバイス及び関連する組立方法
|
|
US20200164155A1
(en)
|
2017-08-09 |
2020-05-28 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
|
US11077246B2
(en)
|
2017-08-18 |
2021-08-03 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
US11759565B2
(en)
|
2017-10-04 |
2023-09-19 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
EP3691716B1
(en)
|
2017-10-06 |
2023-11-29 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
|
MA50348A
(fr)
|
2017-10-09 |
2020-08-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
|
|
WO2019090086A1
(en)
|
2017-11-03 |
2019-05-09 |
Amgen Inc. |
Systems and approaches for sterilizing a drug delivery device
|
|
MA50553A
(fr)
|
2017-11-06 |
2020-09-16 |
Amgen Inc |
Dispositif d'administration de médicament avec détection de positionnement et de débit
|
|
US12053618B2
(en)
|
2017-11-06 |
2024-08-06 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
|
WO2019094138A1
(en)
|
2017-11-10 |
2019-05-16 |
Amgen Inc. |
Plungers for drug delivery devices
|
|
JP2021503311A
(ja)
|
2017-11-16 |
2021-02-12 |
アムジエン・インコーポレーテツド |
失速及び終点検出を有するオートインジェクタ
|
|
CN111278487B
(zh)
|
2017-11-16 |
2022-06-24 |
安进公司 |
用于药物递送装置的门闩锁机构
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
US20210128844A1
(en)
|
2018-07-24 |
2021-05-06 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
US20210260279A1
(en)
|
2018-07-24 |
2021-08-26 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
WO2020023444A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
MA53320A
(fr)
|
2018-07-31 |
2021-11-03 |
Amgen Inc |
Ensemble de trajet de fluide pour dispositif d'administration de médicament
|
|
WO2020068623A1
(en)
|
2018-09-24 |
2020-04-02 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
AR113091A1
(es)
|
2018-09-27 |
2020-01-22 |
Univ Nacional Del Litoral |
Eritropoyetina humana modificada
|
|
IL281469B2
(en)
|
2018-09-28 |
2024-08-01 |
Amgen Inc |
Muscle wire escapement activation assembly for a drug delivery device
|
|
IL281712B2
(en)
|
2018-10-02 |
2025-03-01 |
Amgen Inc |
Injection systems for drug delivery with internal power transmission
|
|
AU2019355979B2
(en)
|
2018-10-05 |
2024-12-05 |
Amgen Inc. |
Drug delivery device having dose indicator
|
|
AR116703A1
(es)
|
2018-10-15 |
2021-06-02 |
Amgen Inc |
Proceso de ensamblaje de plataforma para un dispositivo de administración de fármacos
|
|
IL281894B2
(en)
|
2018-10-15 |
2024-12-01 |
Amgen Inc |
Drug delivery device having damping mechanism
|
|
WO2020091981A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
EP3873566B1
(en)
|
2018-11-01 |
2024-11-27 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
JP7510952B2
(ja)
|
2019-04-24 |
2024-07-04 |
アムジエン・インコーポレーテツド |
シリンジ滅菌確認アセンブリ及び方法
|
|
AU2020337250A1
(en)
|
2019-08-23 |
2022-03-03 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
WO2022159414A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Rochester |
Erythropoietin for gastroinfestinal dysfunction
|
|
EP4341161A1
(en)
|
2021-05-21 |
2024-03-27 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
|
WO2023209074A1
(en)
|
2022-04-28 |
2023-11-02 |
Institut National de la Santé et de la Recherche Médicale |
Methods of restoring erythropoiesis in patients suffering from a sf3b1 mutant myelodysplastic syndrome by correcting coasy mis-splicing
|
|
AU2023374183A1
(en)
|
2022-11-02 |
2025-03-20 |
F. Hoffmann-La Roche Ag |
Method for producing glycoprotein compositions
|